-- ウェドブッシュ証券は金曜日のレポートで、グローバルファウンドリーズ（GFS）は2027年と2028年の業績向上を背景に、目標達成に向けて「より速い転換点」を迎える可能性があると述べた。 レポートによると、同社は2030年以降も二桁の売上高成長、2028年までに粗利益率40%、そして過去12ヶ月間のフリーキャッシュフローの最大50%を配当と自社株買いに充当するという資本還元枠組みを財務目標として設定した。 ウェドブッシュ証券は「この見通しは信憑性が高く、説得力がある」と述べた。同証券は、これらの目標は、高利益率の特殊技術に対する需要の高まりと、特殊技術への注力と多様な製造拠点を背景に、グローバルファウンドリーズの中核能力が新たな市場ニーズを満たすことを前提としていると付け加えた。 ウェドブッシュ証券は、グローバルファウンドリーズの投資判断を「中立」、目標株価を72ドルに据え置いた。
Price: $73.38, Change: $+2.45, Percent Change: +3.45%
Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Healthcare Select Sector SPDR ETF (XLV) shedding 0.9%.The iShares Biotechnology ETF (IBB) was 0.4% higher.In corporate news, Zoetis (ZTS) shares fell 6% after Ameriprise downgraded the stock to hold from buy following its Q1 results Thursday. UBS cut its price target to $99 from $130, and Jefferies to $117 from $155.
Oleg Khaykin, Director, President & CEO, on May 07, 2026, sold 259,880 shares in Viavi Solutions (VIAV) for $13,418,882. Following the Form 4 filing with the SEC, Khaykin has control over a total of 1,188,798 common shares of the company, with 1,188,798 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/912093/000091209326000052/xslF345X05/form4.xmlPrice: $50.62, Change: $-0.43, Percent Change: -0.84%
CIBC Capital Markets maintained its outperformer rating on WSP Global (WSP.TO) but decreased its price target to $318 from $328 after the company reported its first quarter financial results on Wednesday.The bank noted that the company delivered a Q1 beat alongside a "record" backlog and increasing confidence in achieving the low end of its 2027 margin target one year earlier."Management reinforced its consistent message that WSP benefits directly from the AI tailwind, with roughly one-third of net revenues in AI-exposed lines (power & energy, data centers, mining, digital), each experiencing elevated growth," said analyst Krista Friesen. At near 11.0 times 2027 consensus EBITDA, WSP continues to trade at a discount to the broader AI power infrastructure value chain, which has materially re-rated, she noted.CIBC has modestly tweaked its estimates having actualized Q1 earnings and to reflect management's Q2 guidance and its updated 2026 outlook. The bank now sees 2026 EBITDA of near $3.14 billion from $3.09 billion expected earlier, and 2027 EBITDA of near $3.50 billion from $3.48 billion. It has also increased its 2026 EBITDA margin expectation to 19.0% from 18.7%, which is the bottom end of the company's margin guidance for 2027.For 2027, CIBC expects EBITDA margin of 19.5%, up from 19.3%.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $218.38, Change: $-5.80, Percent Change: -2.59%